SCHEMBL6608601

SCHEMBL6608601

COC(=O)c1ccc(OC(=O)CNC(=O)OC(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.49
MAPT P10636 7/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
POLB P06746 1/20 0.47
ELANE P08246 1/20 0.45
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
HIF1A Q16665 1/20 0.44
EPHX2 P34913 1/20 0.44
KMT2A Q03164 4/20 0.43
RAB9A P51151 1/20 0.43
ACR P10323 1/20 0.43
HGFAC Q04756 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423516 0.89 ELANE (0.43) MGLLMAPTCA1CA2POLB
SCHEMBL13690596 0.87 MAPT (0.48) MAPTCA1CA2ELANEALDH1A1
SCHEMBL6985979 0.87 GAA (0.46) MAPTCA1CA2ELANEALDH1A1
SCHEMBL13690601 0.84 HPGD (0.49) MAPTELANEALDH1A1KDM4EGLA
SCHEMBL7423521 0.84 ELANE (0.44) MAPTCA1CA2ELANEALDH1A1
SCHEMBL10866251 0.84 MAPT (0.46) MAPTCA1CA2ELANEALDH1A1
SCHEMBL5849169 0.82 EPHX2 (0.50) MAPTCA1ALDH1A1KDM4EGLA
SCHEMBL26821619 0.80 SMN1; SMN2 (0.54) MAPTCA1CA2ALDH1A1KDM4E
SCHEMBL661882 0.80 MEN1 (0.62) MAPTCA1CA2ALDH1A1KDM4E
SCHEMBL23718635 0.80 AOC3 (0.49) MAPTCA1CA2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289972-B1 SERINE PROTEASE INHIBITORS LILLY CO ELI (US) 2004-09-08 EP disclosed
EP-1289953-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-03-12 EP disclosed
EP-1289950-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-03-12 EP disclosed
EP-1289972-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-03-12 EP disclosed
EP-1289954-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-03-12 EP disclosed
EP-0607439-B1 NITROGENOUS HETEROCYCLIC COMPOUND EISAI CO LTD (JP) 2002-01-09 EP disclosed
WO-2001096304-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2001-12-20 WO disclosed
WO-2001096296-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2001-12-20 WO disclosed
WO-2001096303-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2001-12-20 WO disclosed
WO-2001096323-A1 SERINE PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2001-12-20 WO disclosed
EP-0408034-B1 3-Substituted vinyl cephalosporin derivatives EISAI CO LTD (JP) 1996-05-01 EP disclosed
EP-0686625-A1 ANTHRANILIC ACID DERIVATIVE Eisai Co., Ltd. (JP) 1995-12-13 EP disclosed
EP-0671172-A1 AMINO ACID DERIVATIVE Eisai Co., Ltd. (JP) 1995-09-13 EP disclosed
EP-0669324-A1 QUINAZOLINE COMPOUND Eisai Co., Ltd. (JP) 1995-08-30 EP disclosed
EP-0607439-A1 NITROGENOUS HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 1994-07-27 EP disclosed
US-5329010-A Unsaturated groups with heteroarylalkyl groups and carboxy derivatives EISAI CO., LTD. (JP) 1994-07-12 US disclosed
US-5151417-A Antibiotics and bactericides EISAI CO., LTD. (JP) 1992-09-29 US disclosed
EP-0503426-A1 Quinone derivatives Eisai Co., Ltd. (JP) 1992-09-16 EP disclosed
EP-0484966-A2 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation Eisai Co., Ltd. (JP) 1992-05-13 EP disclosed
EP-0408034-A1 3-Substituted vinyl cephalosporin derivatives Eisai Co., Ltd. (JP) 1991-01-16 EP disclosed